WHO ICTRP trial

A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis Coli Patients…

EUCTR2006-002836-18-GB · EU Clinical Trials Register · Not Recruiting

Key facts

Trial ID EUCTR2006-002836-18-GB
Public title A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid.
Scientific title A Two-Arm Chemoprevention Trial in Familial Adenomatous Polyposis Coli Patients Using the Purified Free Fatty Acid, Eicosapentaenoic Acid.
Primary sponsor S.L.A. Pharma (UK) Ltd
Registry EU Clinical Trials Register
Recruitment status Not Recruiting
Study type Interventional clinical trial of medicinal product
Phase Human pharmacology (Phase I): no Therapeutic exploratory (Phase II): yes Therapeutic confirmatory - (Phase III): no Therapeutic use (Phase IV): no
Countries United Kingdom
Conditions Familial adenomatous polyposis (FAP) MedDRA version: 8.1 Level: LLT Classification code 10059327 Term: Familial adenomatous polyposis
Interventions Product Name: Eicosapentaenoic acid, free fatty acid Product Code: EPA 99% Pharmaceutical Form: Capsule, soft CAS Number: 25378272 Other descriptive name: EICOSAPENTAENOIC ACID Concentration unit: mg milligram(s) Concentration type: equal…
Registration date Nov 6, 2006
Target size 40
Secondary IDs EPA/POL/03
Registry page clinicaltrialsregister.eu

At a glance

  • No Results available

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About WHO ICTRP trial registrations

The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.

Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date:

Browse all WHO ICTRP trial registrations